Results 11 to 20 of about 1,517,186 (231)

Bronchodilator Response in Patients with Persistent Allergic Asthma Could Not Predict Airway Hyperresponsiveness [PDF]

Allergy, Asthma & Clinical Immunology, 2007
Anticholinergics, or specific antimuscarinic agents, by inhibition of muscarinic receptors cause bronchodilatation, which might correlate with activation of these receptors by the muscarinic agonist methacholine.
Petanjek Bojana B, Grle Sanja P, Pelicarić Dubravka, Vranković Dubravka   +3 more
doaj   +2 more sources

Spirometric Indices after Bronchodilator Test in Obstructive Lung Disease [PDF]

Acta Medica Iranica, 2010
"nBronchial responsiveness to bronchodilator medications is usually tested to establish reversibility of airflow obstruction. Among the various tests to establish bronchodilator response, FEV1, FEF25-75% or FEF50%, and FVC are the most widely used ...
Amir Houshang Mehrparvar, Seyed Jalil Mirmohammadi, Mohammad Mehdi Sohrabi   +2 more
doaj   +4 more sources

Comparison of Effectiveness Using Different Dual Bronchodilator Agents in Chronic Obstructive Pulmonary Disease Treatment [PDF]

Journal of Clinical Medicine, 2021
Shih-Lung Cheng
exaly   +2 more sources

Misuse of Inhaled Bronchodilator Agents [PDF]

BMJ: British Medical Journal, 1965
K B Saunders
exaly   +3 more sources

A pragmatic, multicentre, placebo-controlled, 3-arm, double-blinded, randomised controlled trial, incorporating an internal pilot, to determine the role of bronchodilators in preventing exacerbations of bronchiectasis

Health Technology Assessment
Background Bronchiectasis is a long-term lung condition associated with bronchial dilatation, chronic inflammation and infection. Treatment is often empirical or extrapolated from other lung conditions, for example the use of inhaled therapies licensed ...
Nina Wilson, Miranda Morton, Tara Homer, Ann Breeze Konkoth, Richard Joyce, Anneka Kershaw, Hazel Wilde, Alison Liddle, James Wason, Laura Ternent, Maria Allen, Robert Lord, John Steer, Graham Devereux, James D Chalmers, Adam T Hill, Charles S Haworth, John R Hurst, and Anthony De Soyza   +18 more
doaj   +2 more sources

Outcome of ventilation in patients with hypercapnic respiratory failure in IPF patients: A prospective study

Asian Journal of Medical Sciences, 2021
Background: Diffuse parenchymal lung disease (DPLD) is the inflammation and fibrosis of lung interstitium, resulting in respiratory failure. The rate of hypoxic respiratory failure is high as the disease progresses. In idiopathic pulmonary fibrosis (IPF)
Manjunath Hunasenahalli Krishnappa , Prasanna Kumar Thimmarayappa , Vivek Nangia , Rajat Chatterji   +3 more
doaj   +1 more source

Changing patterns in long-acting bronchodilator trials in chronic obstructive pulmonary disease. [PDF]

, 2011
Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality worldwide. Developments in the understanding of COPD have led to standard guidelines for diagnosis, treatment, and spirometry assessments, which have in turn ...
James Donohue, Paul Jones, James F Donohue, Paul W Jones, Donohue, JF, Jones, PW   +5 more
core   +1 more source

Serum magnesium levels and its correlation with level of control in patients with asthma: A hospital-based, cross-sectional, prospective study

Lung India, 2018
Context: Magnesium (Mg) is an intracellular cation which takes part in various functions including smooth muscle contractility. Studies have shown that serum Mg level has no significant effect on asthma severity.
Vasudev Malik Daliparty, Mohan K Manu, Aswini Kumar Mohapatra   +2 more
doaj   +1 more source

Overprescription of short‐acting β2‐agonists among patients with asthma in Saudi Arabia: Results from the SABINA III cohort study

The Clinical Respiratory Journal, 2022
Despite near‐universal health care and timely updates to treatment guidelines in Saudi Arabia, asthma control remains suboptimal, warranting deeper exploration of its management practices.
Hamdan Al‐Jahdali, Siraj Wali, Amr S. Albanna, Abeer Al Harbi, Riyad Allehebi, Abdulmajed Arwadi, Tarek Dahan, Mohamed Fattouh, Ezzat Hamza, Maarten Beekman   +9 more
doaj   +1 more source

Long-acting β2-adrenergic receptor agonist in pediatric asthma

Allergology International, 2004
Long-acting β2-adrenergic receptor agonists (LABA), a class of agents for the long-term management of childhood bronchial asthma, are recommended for use in combination with steroid inhalation for the treatment of the morning dip in severe childhood ...
Shigemi Yoshihara, Yumi Yamada, Toshio Abe, Osamu Arisaka   +3 more
doaj   +1 more source